Aché To Capitalise On Upcoming Patent Expiries

Brazilian pharmaceutical company Aché is investing US$120mn in its production capabilities in anticipation of the upcoming patent cliff, with around 25 brands of medicines set to lose intellectual property protection from 2010-2011. José Ricardo Mendes da Silva, president of Aché, told Valor Econômico that the company has 100 projects that will be launched over the next three years, with 10 generics or similares to be launched in 2010. BMI believes Aché's proactive stance in the generics space should see it continue to perform strongly over the medium

To read the full article, please choose one of the following options: